Usharani - Prometheus IP - Page 3

The Delhi high court issued notice to the Government of India on Sep 1st 2015, in response to a public interest litigation (PIL) on working of patents filed by eminent IP professional, Shamnad Basheer and the matter is now listed for November 17th. The PIL was filed based on the outcome of a survey undertaken...

India’s compulsory licensing policy, though TRIPS compliant, has come under scathing attack from many quarters of developed countries, mainly attributed to the pressure from big pharma lobbies based in those countries. India granted its first compulsory license in Mar 2012 to NATCO Pharma Ltd., a generic drug manufacturer, to produce Nexaver, an anticancer drug patented...

Patient organizations gained a victory in their fight for access to medicines as Roche’s patent on Valganciclovir, an antiviral medication was revoked by the Chennai Patent Office. But this long drawn fight is not a clear victory since the patent term expired almost simultaneously. Background: Roche filed a patent application (959/MAS/1995) with the Indian Patent...

The Delhi High Court in its interim order dated 17th July 2015, disposed off the appeal filed by Glenmark against the interim injunction awarded by a single judge of the Delhi High Court on 19th Jan 2015. The 19th Jan 2015 interim injunction restrained Glenmark from making linezolid on the ground that it violated Symed’s...

As per Thomson Reuter’s analysis of global patents, the life sciences industry is attaining increasing succession over technology-based sectors in terms of driving global innovation. The year 2014 has been full of patents application and successful grants than any other year in the history. This reflects the ingenious nature of civilization with relevance to few...

In a case reflecting the sorry state of affairs with respect to patent prosecution in India, the Intellectual Property Appellate Board (IPAB) had set aside the order passed by the Delhi Patent Office refusing patent to Pfizer’s anti-psychotic drug. Pfizer’s patent application (No. 1154/DEL/1997) was directed to Ziprasidone mesylate trihydrate for treatment of psychotic disorders....

Janssen Pharmaceuticals, a pharmaceutical company of Johnson & Johnson, has announced an expanded policy on improved accessibility of medicines in which the geographic scope of its earlier 2012 policy of waiving enforcement of patent rights for pediatric formulations of Darunavir, is expanded. This expansion includes many low and middle income countries including India, Pakistan and...

Indus Foundation, a registered non-profit trust for promoting healthcare in India is organizing three summits viz. Indo-Global Pharma Expo and Summit 2015, Indo-Global Medical Expo and Summit 2015 and Indo-Global Healthcare Expo and Summit 2015, from July 23 to July 26, 2015 at Hyderabad. Indus Foundation is organizing this summit in association with Federation of...

COEO Labs, a medical technology startup, based in Bangalore has filed patent application for protecting an automated tracheal secretion management device, VAPCare that is developed by the company. The medical device is designed to prevent ventilation associated pneumonia in patients under critical care.

Suven Life Sciences Ltd., from Hyderabad, specializing in research on new drug candidates for central nervous system (CNS) disorders had procured two new product patents – one from the European patent office (EPO) and another from Hongkong. Both the patents claim drug compounds (New Chemical Entities- NCEs) targeting a serotonin receptor that modulates the release...